20 states sue to end ACA after mandate repeal

In 2012, the U.S. Supreme Court upheld the constitutionality of the Affordable Care Act (ACA)’s individual mandate. With the mandate’s penalty now eliminated under President Donald Trump, 20 states are using the earlier ruling as the basis for a new lawsuit seeking to “effectively repeal Obamacare.”

Of the 20 state attorneys general in the complaint, only two—Maine and Mississippi—are Democrats. Their argument centers on the 2012 ruling in National Federation of Independent Business v. Sebelius, where Supreme Court ruled the individual mandate was allowed because the penalty acted like a tax but rejected the Obama administration’s position that the requirement for individuals to buy health coverage fell under Congress’s power to regulate interstate commerce.

Now that the penalty has been zeroed out under the Republican-backed tax cut law, what remains is a requirement which Supreme Court justices have ruled is unconstitutional, the suit argues.

“With no remaining legitimate basis for the law, it is time that Americans are finally free from the stranglehold of Obamacare, once and for all,” Texas Attorney General Ken Paxton said in a press release.

Besides Texas, the states involved are: Alabama, Arkansas, Arizona, Florida, Georgia, Indiana, Kansas, Louisiana, Maine, Mississippi, Missouri, Nebraska, North Dakota, South Carolina, South Dakota, Tennessee, Utah, West Virginia and Wisconsin.

The stated goal of the suit, Paxton said, is to repeal the ACA so it can be replaced by Republicans in Congress. Several legislative efforts to do just that failed in 2017, and the party’s legislative leaders have indicated they have no plans to tackle large-scale healthcare reforms ahead of the midterm elections in November.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.